Primary angiosarcoma of the ovary: a case report of Stage I disease
Department of Obstetrics and Gynecology
Adult; Antineoplastic Combined Chemotherapy Protocols; dosage; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Female; Hemangiosarcoma; Humans; Ifosfamide; Mesna; Neoplasm Staging; Ovarian Neoplasms
Obstetrics and Gynecology
BACKGROUND: There are 20 documented cases of primary ovarian angiosarcoma. Most patients present with metastatic disease and respond poorly to chemotherapy. There is little information available to counsel early-staged patients on the need for or efficacy of adjuvant chemotherapy.
CASE: We present a case of Stage Ic primary ovarian angiosarcoma treated with 3 cycles of adjuvant MAID chemotherapy. The patient is without evidence of disease 10 months post-operatively.
CONCLUSION: A review of the literature indicates a potential role for MAID chemotherapy in the treatment of ovarian angiosarcomas. Detection of Stage I disease appears to confer a better prognosis regardless of the utilization of adjuvant chemotherapy.
DOI of Published Version
Gynecol Oncol. 2005 Oct;99(1):218-21. Link to article on publisher's site
Quesenberry CD, Li C, Chen AH, Zweizig SL, Ball HG. (2005). Primary angiosarcoma of the ovary: a case report of Stage I disease. Obstetrics and Gynecology Publications and Presentations. https://doi.org/10.1016/j.ygyno.2005.05.044. Retrieved from https://escholarship.umassmed.edu/obgyn_pp/28